These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9818195)

  • 21. Molecular mechanisms of Bartter syndrome caused by mutations in the BSND gene.
    Hayama A; Rai T; Sasaki S; Uchida S
    Histochem Cell Biol; 2003 Jun; 119(6):485-93. PubMed ID: 12761627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ClC and CFTR chloride channel gating.
    Foskett JK
    Annu Rev Physiol; 1998; 60():689-717. PubMed ID: 9558482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The diuretic- and Bartter-like salt-losing tubulopathies.
    Jeck N; Konrad M; Hess M; Seyberth HW
    Nephrol Dial Transplant; 2000; 15 Suppl 6():19-20. PubMed ID: 11143975
    [No Abstract]   [Full Text] [Related]  

  • 24. X-linked hypercalciuric nephrolithiasis: clinical syndromes and chloride channel mutations.
    Scheinman SJ
    Kidney Int; 1998 Jan; 53(1):3-17. PubMed ID: 9452994
    [No Abstract]   [Full Text] [Related]  

  • 25. Barttin is a Cl- channel beta-subunit crucial for renal Cl- reabsorption and inner ear K+ secretion.
    Estévez R; Boettger T; Stein V; Birkenhäger R; Otto E; Hildebrandt F; Jentsch TJ
    Nature; 2001 Nov; 414(6863):558-61. PubMed ID: 11734858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mice lacking renal chloride channel, CLC-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis.
    Wang SS; Devuyst O; Courtoy PJ; Wang XT; Wang H; Wang Y; Thakker RV; Guggino S; Guggino WB
    Hum Mol Genet; 2000 Dec; 9(20):2937-45. PubMed ID: 11115837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ClC-K chloride channels: emerging pathophysiology of Bartter syndrome type 3.
    Andrini O; Keck M; Briones R; Lourdel S; Vargas-Poussou R; Teulon J
    Am J Physiol Renal Physiol; 2015 Jun; 308(12):F1324-34. PubMed ID: 25810436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anoctamin 1 induces calcium-activated chloride secretion and proliferation of renal cyst-forming epithelial cells.
    Buchholz B; Faria D; Schley G; Schreiber R; Eckardt KU; Kunzelmann K
    Kidney Int; 2014 May; 85(5):1058-67. PubMed ID: 24152967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of Disease: the kidney-specific chloride channels ClCKA and ClCKB, the Barttin subunit, and their clinical relevance.
    Krämer BK; Bergler T; Stoelcker B; Waldegger S
    Nat Clin Pract Nephrol; 2008 Jan; 4(1):38-46. PubMed ID: 18094726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ICln, a chloride channel cloned from kidney cells, is activated during regulatory volume decrease.
    Laich A; Gschwentner M; Krick W; Nagl UO; Fürst J; Hofer S; Susanna A; Schmarda A; Deetjen P; Burckhardt G; Paulmichl M
    Kidney Int; 1997 Feb; 51(2):477-8. PubMed ID: 9027725
    [No Abstract]   [Full Text] [Related]  

  • 31. Novel CLCNKB mutations causing Bartter syndrome affect channel surface expression.
    Keck M; Andrini O; Lahuna O; Burgos J; Cid LP; Sepúlveda FV; L'hoste S; Blanchard A; Vargas-Poussou R; Lourdel S; Teulon J
    Hum Mutat; 2013 Sep; 34(9):1269-78. PubMed ID: 23703872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical genetics. Crystal-clear chloride channels.
    Hebert SC
    Nature; 1996 Feb; 379(6564):398-9. PubMed ID: 8559242
    [No Abstract]   [Full Text] [Related]  

  • 33. ClC-5 chloride channel and kidney stones: what is the link?
    Silva IV; Morales MM; Lopes AG
    Braz J Med Biol Res; 2001 Mar; 34(3):315-23. PubMed ID: 11262581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endocochlear potential depends on Cl- channels: mechanism underlying deafness in Bartter syndrome IV.
    Rickheit G; Maier H; Strenzke N; Andreescu CE; De Zeeuw CI; Muenscher A; Zdebik AA; Jentsch TJ
    EMBO J; 2008 Nov; 27(21):2907-17. PubMed ID: 18833191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Barttin increases surface expression and changes current properties of ClC-K channels.
    Waldegger S; Jeck N; Barth P; Peters M; Vitzthum H; Wolf K; Kurtz A; Konrad M; Seyberth HW
    Pflugers Arch; 2002 Jun; 444(3):411-8. PubMed ID: 12111250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of human CIC-2 Cl- channels: implications for cystic fibrosis.
    Cuppoletti J; Tewari KP; Sherry AM; Malinowska DH
    Clin Exp Pharmacol Physiol; 2000 Nov; 27(11):896-900. PubMed ID: 11071306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chloride channelopathies.
    Planells-Cases R; Jentsch TJ
    Biochim Biophys Acta; 2009 Mar; 1792(3):173-89. PubMed ID: 19708126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bartter's syndrome].
    Daniluk U; Kaczmarski M; Wasilewska J; Matuszewska E; Semeniuk J; Sidor K; Krasnow A
    Pol Merkur Lekarski; 2004 May; 16(95):484-9. PubMed ID: 15518434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salt-losing nephropathy in mice with a null mutation of the Clcnk2 gene.
    Grill A; Schießl IM; Gess B; Fremter K; Hammer A; Castrop H
    Acta Physiol (Oxf); 2016 Nov; 218(3):198-211. PubMed ID: 27421685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cloning and characterization of CLCN5, the human kidney chloride channel gene implicated in Dent disease (an X-linked hereditary nephrolithiasis).
    Fisher SE; van Bakel I; Lloyd SE; Pearce SH; Thakker RV; Craig IW
    Genomics; 1995 Oct; 29(3):598-606. PubMed ID: 8575751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.